Hicks Derek
EVP, Chief Business Officer at NTLA
- Sold, on record
- $261k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jan 3, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NTLAIntellia Therapeutics, Inc.EVP, Chief Business Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NTLAPlan not statedJan 4, 2023 2023
Sold 1,812 shares at $37.21 ($67k)
Hicks Derek, EVP, Chief Business Officer
Sold 9.5% of holdings ($711k position)17,306 shares leftFirst sale on recordFiling
- 2 Form 4 sale NTLANo planJan 3, 2024 +364 days
Sold 3,877 shares at $29.46 ($114k)
Hicks Derek, EVP, Chief Business Officer
No 10b5-1 planSold 9.5% of holdings ($1.2M position)36,987 shares leftFiling
- 3 Form 4 sale NTLANo planJan 3, 2025 +366 days
Sold 6,502 shares at $12.18 ($79k)
Hicks Derek, EVP, Chief Business Officer
No 10b5-1 planSold 9.8% of holdings ($809k position)59,878 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | Jan 7, 2025 | NTLA | EVP, Chief Business Officer | Form 4 sale | 6,502 | $79k | 9.8% | No plan | SEC |
| Jan 3, 2024 | Jan 5, 2024 | NTLA | EVP, Chief Business Officer | Form 4 sale | 3,877 | $114k | 9.5% | No plan | SEC |
| Jan 4, 2023 | Jan 6, 2023 | NTLA | EVP, Chief Business Officer | Form 4 sale | 1,812 | $67k | 9.5% | Plan not stated | SEC |